Analgesics (Pharmacies) - Eastern Europe

  • Eastern Europe
  • Revenue in the Analgesics market is projected to reach US$3.14bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.13%, resulting in a market volume of US$4.43bn by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$13.21 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Eastern Europe has been experiencing steady growth in recent years.

Customer preferences:
Customers in Eastern Europe have shown a strong preference for analgesics purchased from pharmacies. This preference can be attributed to the trust and reliability associated with pharmacies, as well as the availability of professional advice from pharmacists. Customers in the region also value the convenience of being able to purchase analgesics alongside other healthcare products in one location.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Eastern Europe is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to several factors. Firstly, customers in the region are becoming more proactive about managing their health and are seeking self-care options. OTC analgesics provide a convenient and accessible solution for minor pain relief. Secondly, the rising healthcare costs in Eastern Europe have led to a greater emphasis on preventive care and self-treatment, further driving the demand for OTC analgesics. Another trend in the market is the growing popularity of natural and herbal analgesics. Customers in Eastern Europe are increasingly seeking alternatives to conventional analgesics, driven by a desire for more natural and holistic remedies. This trend is also influenced by the rising awareness of the potential side effects associated with long-term use of traditional analgesics. As a result, pharmacies in Eastern Europe are expanding their product offerings to include a wider range of natural and herbal analgesics to cater to this demand.

Local special circumstances:
Eastern Europe is a diverse region with varying healthcare systems and regulations. In some countries, the healthcare system is primarily publicly funded, leading to a higher reliance on prescription analgesics. In contrast, other countries have a more liberal approach to the sale of analgesics, allowing for greater accessibility and availability of OTC options. These local special circumstances influence the market dynamics and customer preferences in each country.

Underlying macroeconomic factors:
The Analgesics (Pharmacies) market in Eastern Europe is also influenced by underlying macroeconomic factors. The region has been experiencing economic growth, leading to an increase in disposable income and healthcare spending. This has contributed to the overall growth of the market as customers have more purchasing power to spend on analgesics. Additionally, the aging population in Eastern Europe has also contributed to the growth of the market, as older individuals are more likely to require analgesics for chronic pain management. In conclusion, the Analgesics (Pharmacies) market in Eastern Europe is developing due to customer preferences for pharmacy-purchased analgesics, the increasing demand for OTC options, the growing popularity of natural and herbal analgesics, local special circumstances within each country, and underlying macroeconomic factors such as economic growth and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)